Mostrando 61 - 80 Resultados de 2,531 Para Buscar 'Stephen Wayda~', tiempo de consulta: 1.65s Limitar resultados
  1. 61
  2. 62
  3. 63
    “….: Honoraria|Roche: Honoraria|Roche: This project has been funded by BARDA (HHSO100201600038C). Federica Monti, PhD, Allecra: Study funded|Innoviva Specialty Therapeutics, Inc.: Honoraria Stephen Hawser, PhD, Allecra: study funding|Innoviva Specialty Therapeutics, Inc.: Honoraria|Roche: Honoraria|Roche: This project has been funded by BARDA (HHSO100201600038C).…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  4. 64
  5. 65
  6. 66
  7. 67
  8. 68
  9. 69
    “…These data support the continued clinical development of zosurabalpin for infections caused by ABC isolates, including difficult to treat carbapenem-resistant isolates. DISCLOSURES: Stephen Hawser, PhD, Allecra: study funding|Innoviva Specialty Therapeutics, Inc.: Honoraria|Roche: Honoraria|Roche: This project has been funded by BARDA (HHSO100201600038C). …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  10. 70
    “…These results suggest that, following several years of clinical use, susceptibility to eravacycline remains high. DISCLOSURES: Stephen Hawser, PhD, Allecra: study funding|Innoviva Specialty Therapeutics, Inc.: Honoraria|Roche: Honoraria|Roche: This project has been funded by BARDA (HHSO100201600038C). …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  11. 71
    “…Harmonization of clinical breakpoints for eravacycline would be desirable. DISCLOSURES: Stephen Hawser, PhD, Allecra: study funding|Innoviva Specialty Therapeutics, Inc.: Honoraria|Roche: Honoraria|Roche: This project has been funded by BARDA (HHSO100201600038C). …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  12. 72
  13. 73
  14. 74
  15. 75
  16. 76
  17. 77
  18. 78
  19. 79
  20. 80
Herramientas de búsqueda: RSS